agilon health (AGL)

Healthcare · Medical Care Facilities
$82.39 -2.75% on the day Market cap $1.6B 52-week range $7.48 to $133.04 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

agilon health's free cash flow was negative in fiscal 2025, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

F

Five factors scored 1 to 9 from AGL's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability0
Growth5
Financial health2
Cash efficiency0

Results from SEC filings

Fiscal years, from agilon health's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$1.5B$2.4B$4.3B$6.1B$5.9B
Net income-$406M-$107M-$263M-$260M-$391M
Free cash flow-$155M-$146M-$172M-$71M-$119M
EPS (diluted)—————
Operating margin-24.5%-4.4%-5.4%-4.8%-7.8%

Where the revenue comes from

Revenue by products, fiscal 2025. Every breakdown, year by year.

Medical services revenue$5.9B100%
Other operating revenue$11M0%

Superinvestors who own AGL

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Cliff Asness
AQR Capital Management
Trimmed $74M0.03%Q2 2026
Joel Greenblatt
Gotham Asset Management
New position $607,3890.00%Q2 2026

Insider buying

Open-market purchases by agilon health's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Nov 12, 2025 John William Wulf
3,240$15.75$51,030

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when AGL trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are agilon health insiders buying the stock?

1 open-market insider purchase of AGL in the last 12 months, from SEC Form 4 filings.

Which superinvestors own agilon health?

2 of the superinvestors Investingly tracks hold AGL in their latest 13F, including Cliff Asness, Joel Greenblatt.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.